Characterization of Atxn2 in ALS Patient Samples and Insight into ASO Therapy

被引：0
|
作者：
Taylor, Amy [1 ]
Garcia, Sandra Diaz [1 ]
Rodriguez, Maria [1 ]
Ravits, John [2 ]
机构：
[1] Univ Calif San Diego, Neurosci, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S5.001
引用
收藏
页数：2
相关论文
共 33 条
  • [21] Novel AAV-Capsid-Mediated Delivery of an RNAi Targeting Atxn2 Extends Survival and Improves Strength and Neuroinflammation in a Mouse Model of Sporadic ALS
    Amado, Defne A.
    Monteys, Alejandro Mas
    Whiteman, Katherine
    Smith, Alicia R.
    Bosch, Guillem Chillon
    Izda, Aleksandar
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2023, 31 (04) : 2 - 2
  • [22] Improved Survival, Strength, Weight, and Neuroinflammation in a Mouse Model of Sporadic ALS after Novel AAV-Mediated Delivery of RNAi Targeting Atxn2
    Amado, Defne A.
    Whiteman, Katherine
    Smith, Alicia R.
    Bosch, Guillem Chillon
    Monteys, Alejandro Mas
    Robbins, Ashley
    Izda, Aleksandar
    Nelson, Shareen
    Davidson, Beverly L.
    ANNALS OF NEUROLOGY, 2023, 94 : S217 - S218
  • [23] Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotype
    Ghezzi, Andrea
    Martinelli, Ilaria
    Carra, Serena
    Mediani, Laura
    Zucchi, Elisabetta
    Simonini, Cecilia
    Gianferrari, Giulia
    Fini, Nicola
    Cereda, Cristina
    Gellera, Cinzia
    Pensato, Viviana
    Mandrioli, Jessica
    NEUROLOGICAL SCIENCES, 2022, 43 (10) : 6087 - 6090
  • [24] Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotype
    Andrea Ghezzi
    Ilaria Martinelli
    Serena Carra
    Laura Mediani
    Elisabetta Zucchi
    Cecilia Simonini
    Giulia Gianferrari
    Nicola Fini
    Cristina Cereda
    Cinzia Gellera
    Viviana Pensato
    Jessica Mandrioli
    Neurological Sciences, 2022, 43 : 6087 - 6090
  • [25] Intermediate CAG Repeat Expansion in the ATXN2 Gene Is a Unique Genetic Risk Factor for ALS-A Systematic Review and Meta-Analysis of Observational Studies
    Wang, Ming-Dong
    Gomes, James
    Cashman, Neil R.
    Little, Julian
    Krewski, Daniel
    PLOS ONE, 2014, 9 (08):
  • [26] The Clinical and Ploynucleotide Repeat Expansion Analysis of ATXN2, NOP56, AR and C9orf72 in Patients With ALS From Mainland China
    Hou, Xiaorong
    Li, Wanzhen
    Liu, Pan
    Liu, Zhen
    Yuan, Yanchun
    Ni, Jie
    Shen, Lu
    Tang, Beisha
    Wang, Junling
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [27] The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway
    Ciura, Sorana
    Sellier, Chantal
    Campanari, Maria-Letizia
    Charlet-Berguerand, Nicolas
    Kabashi, Edor
    AUTOPHAGY, 2016, 12 (08) : 1406 - 1408
  • [28] Characterization of Transforming NTRK2 and NTRK3 Mutations Identified in Leukemia Patient Samples
    Qian, Kristin
    Tognon, Cristina E.
    Wagner, Jacob
    Davare, Monika
    Druker, Brian J.
    BLOOD, 2016, 128 (22)
  • [29] Characterization of a novel 2D array dosimeter for patient-specific quality assurance with volumetric arc therapy
    Stathakis, Sotirios
    Myers, Pamela
    Esquivel, Carlos
    Mavroidis, Panayiotis
    Papanikolaou, Nikos
    MEDICAL PHYSICS, 2013, 40 (07)
  • [30] 2 MALIGNANT PERIPHERAL PRIMITIVE NEUROEPITHELIAL TUMOR-CELL LINES ESTABLISHED FROM CONSECUTIVE SAMPLES OF ONE PATIENT - CHARACTERIZATION AND CYTOGENETIC ANALYSIS
    KEES, UR
    RUDDUCK, C
    FORD, J
    SPAGNOLO, D
    PAPADIMITRIOU, J
    WILLOUGHBY, MLN
    GARSON, OM
    GENES CHROMOSOMES & CANCER, 1992, 4 (03): : 195 - 204
1234